These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24287905)

  • 21. Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines.
    Nakashima A; Hayashi N; Kaneko YS; Mori K; Sabban EL; Nagatsu T; Ota A
    J Neural Transm (Vienna); 2009 Nov; 116(11):1355-62. PubMed ID: 19396395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism.
    Zigmond MJ; Acheson AL; Stachowiak MK; Stricker EM
    Arch Neurol; 1984 Aug; 41(8):856-61. PubMed ID: 6147127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
    Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
    Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of tyrosine hydroxylase in parkinsonian brains and in the brains of MPTP-treated mice.
    Nagatsu T
    Adv Neurol; 1990; 53():207-14. PubMed ID: 1978515
    [No Abstract]   [Full Text] [Related]  

  • 25. Human tyrosine hydroxylase in Parkinson's disease and in related disorders.
    Nagatsu T; Nakashima A; Ichinose H; Kobayashi K
    J Neural Transm (Vienna); 2019 Apr; 126(4):397-409. PubMed ID: 29995172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular mechanism of brain regeneration and reconstruction of dopaminergic neural network in planarians].
    Nishimura K; Kitamura Y; Agata K
    Brain Nerve; 2008 Apr; 60(4):307-17. PubMed ID: 18421972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
    Taniguchi R; Nakagawasai O; Tan-no K; Yamadera F; Nemoto W; Sato S; Yaoita F; Tadano T
    Biosci Biotechnol Biochem; 2013; 77(2):266-70. PubMed ID: 23391905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.
    Xu Y; Stokes AH; Roskoski R; Vrana KE
    J Neurosci Res; 1998 Dec; 54(5):691-7. PubMed ID: 9843160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
    King JM; Muthian G; Mackey V; Smith M; Charlton C
    Life Sci; 2011 Oct; 89(17-18):638-43. PubMed ID: 21871902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconstruction of dopaminergic neural network and locomotion function in planarian regenerates.
    Nishimura K; Kitamura Y; Inoue T; Umesono Y; Sano S; Yoshimoto K; Inden M; Takata K; Taniguchi T; Shimohama S; Agata K
    Dev Neurobiol; 2007 Jul; 67(8):1059-78. PubMed ID: 17565705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copper sulfate prevents tyrosine hydroxylase reduced activity and motor deficits in a Parkinson's disease model in mice.
    Alcaraz-Zubeldia M; Boll-Woehrlen MC; Montes-López S; Pérez-Severiano F; Martínez-Lazcano JC; Díaz-Ruiz A; Ríos C
    Rev Invest Clin; 2009; 61(5):405-11. PubMed ID: 20184101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous dopaminergic tone and dopamine agonist action.
    Treseder SA; Smith LA; Jenner P
    Mov Disord; 2000 Sep; 15(5):804-12. PubMed ID: 11009183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a rat model of gestational hypothyroidism on forebrain dopaminergic, GABAergic, and serotonergic systems and related behaviors.
    Menezes EC; Santos PR; Goes TC; Carvalho VCB; Teixeira-Silva F; Stevens HE; Badauê-Passos DJ
    Behav Brain Res; 2019 Jul; 366():77-87. PubMed ID: 30898681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
    Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
    Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.
    Casarejos MJ; Menéndez J; Solano RM; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
    J Neurochem; 2006 May; 97(4):934-46. PubMed ID: 16573651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.
    Rangasamy SB; Dasarathi S; Pahan P; Jana M; Pahan K
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):173-187. PubMed ID: 30187283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors.
    Joyce JN; Ryoo HL; Beach TB; Caviness JN; Stacy M; Gurevich EV; Reiser M; Adler CH
    Brain Res; 2002 Nov; 955(1-2):138-52. PubMed ID: 12419530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
    Kastner A; Hirsch EC; Herrero MT; Javoy-Agid F; Agid Y
    J Neurochem; 1993 Sep; 61(3):1024-34. PubMed ID: 8103078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.